Gary L. Johnson

45.1k total citations · 7 hit papers
407 papers, 36.0k citations indexed

About

Gary L. Johnson is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Gary L. Johnson has authored 407 papers receiving a total of 36.0k indexed citations (citations by other indexed papers that have themselves been cited), including 282 papers in Molecular Biology, 52 papers in Oncology and 51 papers in Cell Biology. Recurrent topics in Gary L. Johnson's work include Protein Kinase Regulation and GTPase Signaling (99 papers), Melanoma and MAPK Pathways (90 papers) and Receptor Mechanisms and Signaling (42 papers). Gary L. Johnson is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (99 papers), Melanoma and MAPK Pathways (90 papers) and Receptor Mechanisms and Signaling (42 papers). Gary L. Johnson collaborates with scholars based in United States, Germany and Finland. Gary L. Johnson's co-authors include Razvan Lapadat, Christian Widmann, Spencer B. Gibson, Carol A. Lange, Matthew Jarpe, Timothy Garrington, Lynn E. Heasley, Anne M. Gardner, Amy N. Abell and Lester Andrews and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Gary L. Johnson

390 papers receiving 35.1k citations

Hit Papers

Mitogen-Activated Protein Kinase Pathways Mediated by ERK... 1993 2026 2004 2015 2002 1999 1999 1994 1993 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
    2002 3.6k citations Gary L. Johnson et al. profile →
  2. Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
    1999 2.3k citations Gary L. Johnson et al. profile →
  3. Organization and regulation of mitogen-activated protein kinase signaling pathways
    1999 1.1k citations Gary L. Johnson et al. profile →
  4. Differential Activation of ERK and JNK Mitogen-Activated Protein Kinases by Raf-1 and MEKK
    1994 998 citations Carol A. Lange, Gary L. Johnson et al. profile →
  5. A Divergence in the MAP Kinase Regulatory Network Defined by MEK Kinase and Raf
    1993 973 citations Carol A. Lange, Anne M. Gardner et al. profile →
  6. Coordination of Rho GTPase activities during cell protrusion
    2009 740 citations Gary L. Johnson et al. profile →
  7. Identification of a Dual Specificity Kinase That Activates the Jun Kinases and p38-Mpk2
    1995 706 citations Carol A. Lange, Gary L. Johnson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary L. Johnson United States 94 23.5k 6.1k 5.7k 4.6k 4.2k 407 36.0k
Garth L. Nicolson United States 90 19.9k 0.8× 4.6k 0.8× 6.3k 1.1× 5.3k 1.2× 4.7k 1.1× 414 32.8k
Julian Downward United Kingdom 101 30.1k 1.3× 5.1k 0.8× 11.4k 2.0× 5.9k 1.3× 4.9k 1.2× 292 41.7k
Jiahuai Han China 107 29.9k 1.3× 11.0k 1.8× 5.8k 1.0× 3.7k 0.8× 6.7k 1.6× 319 44.0k
William S. Lane United States 92 28.0k 1.2× 3.9k 0.6× 5.5k 1.0× 3.9k 0.9× 6.8k 1.6× 201 36.8k
Jacques Pouysségur France 113 29.0k 1.2× 3.7k 0.6× 6.1k 1.1× 4.1k 0.9× 12.3k 3.0× 369 42.1k
Guy S. Salvesen United States 110 37.2k 1.6× 9.6k 1.6× 9.0k 1.6× 5.5k 1.2× 8.2k 2.0× 295 54.7k
Tatsuhiko Kodama Japan 89 20.1k 0.9× 9.3k 1.5× 6.7k 1.2× 2.0k 0.4× 4.9k 1.2× 426 36.3k
Steven A. Carr United States 108 31.7k 1.3× 3.5k 0.6× 5.4k 0.9× 6.3k 1.4× 4.0k 1.0× 372 44.4k
Elisabetta Dejana Italy 113 22.7k 1.0× 7.2k 1.2× 5.6k 1.0× 8.4k 1.8× 4.6k 1.1× 389 44.0k
Naoyuki Taniguchi Japan 98 23.8k 1.0× 11.3k 1.9× 3.9k 0.7× 4.5k 1.0× 2.4k 0.6× 1.1k 41.6k

Countries citing papers authored by Gary L. Johnson

Since Specialization
Citations

This map shows the geographic impact of Gary L. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary L. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary L. Johnson more than expected).

Fields of papers citing papers by Gary L. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary L. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary L. Johnson. The network helps show where Gary L. Johnson may publish in the future.

Co-authorship network of co-authors of Gary L. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Gary L. Johnson. A scholar is included among the top collaborators of Gary L. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary L. Johnson. Gary L. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matkar, Smita, Michael P. East, Timothy J. Stuhlmiller, et al.. (2025). Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma. Molecular Cancer Therapeutics. 24(9). 1389–1401. 2 indexed citations
2.
Berginski, Matthew E., Brian T. Golitz, Matthew B. Lipner, et al.. (2024). Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines. PeerJ. 12. e17797–e17797.
3.
Mehta, Gaurav, Steven P. Angus, Kevin Tong, et al.. (2021). SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2. npj Breast Cancer. 7(1). 40–40. 14 indexed citations
4.
Goulet, Daniel R., Jon S. Zawistowski, Samantha M. Bevill, et al.. (2020). Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer. Molecular Cancer Research. 18(11). 1685–1698. 3 indexed citations
5.
Bevill, Samantha M., Noah Sciaky, Brian T. Golitz, et al.. (2019). GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer. Molecular Cancer Research. 17(7). 1503–1518. 44 indexed citations
6.
Cousins, Emily, Dennis Goldfarb, Feng Yan, et al.. (2017). Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3β and Activates WNT Signaling. Molecular Cancer Research. 16(2). 333–344. 32 indexed citations
7.
Brighton, Hailey E., Steven P. Angus, Tao Bo, et al.. (2017). New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging. Cancer Research. 78(2). 542–557. 57 indexed citations
8.
Swearingen, Amanda E.D. Van, Maria J. Sambade, Marni B. Siegel, et al.. (2017). Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer. Neuro-Oncology. 19(11). 1481–1493. 32 indexed citations
9.
Miller, Samantha M., Daniel R. Goulet, & Gary L. Johnson. (2016). Targeting the Breast Cancer Kinome. Journal of Cellular Physiology. 232(1). 53–60. 23 indexed citations
10.
Roberts, Patrick J., Jerry Usary, David B. Darr, et al.. (2012). Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models. Clinical Cancer Research. 18(19). 5290–5303. 107 indexed citations
11.
Johnson, Gary L. & Kazuhiro Nakamura. (2007). The c-jun kinase/stress-activated pathway: Regulation, function and role in human disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773(8). 1341–1348. 403 indexed citations
12.
Johnson, Gary L., et al.. (1999). Developments in natural gas liquefaction : Gas processing developments: a special report. Hydrocarbon processing. 78(4). 47–59. 28 indexed citations
13.
Nick, Jerry A., Natalie J. Avdi, S K Young, et al.. (1999). Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. Journal of Clinical Investigation. 103(6). 851–858. 248 indexed citations
14.
Ishizuka, Tamotsu, Hideki Kawasome, Naohiro Terada, et al.. (1998). Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.. PubMed. 161(7). 3624–30. 48 indexed citations
15.
Nick, Jerry A., Natalie J. Avdi, S K Young, et al.. (1997). Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP.. Journal of Clinical Investigation. 99(5). 975–986. 265 indexed citations
16.
Buhl, Anne Mette, Shoji Osawa, & Gary L. Johnson. (1995). Mitogen-activated Protein Kinase Activation Requires Two Signal Inputs from the Human Anaphylatoxin C5a Receptor. Journal of Biological Chemistry. 270(34). 19828–19832. 56 indexed citations
17.
Lange, Carol A. & Gary L. Johnson. (1995). [30] Assay of MEK kinases. Methods in enzymology on CD-ROM/Methods in enzymology. 255. 290–301. 18 indexed citations
18.
Gardner, Anne M., Carol A. Lange, Rosaire Vaillancourt, & Gary L. Johnson. (1994). [22] Measuring activation of kinases in mitogen-activated protein kinase regulatory network. Methods in enzymology on CD-ROM/Methods in enzymology. 238. 258–270. 61 indexed citations
19.
Russell, Marijane, S Winitz, & Gary L. Johnson. (1994). Acetylcholine Muscarinic m1 Receptor Regulation of Cyclic AMP Synthesis Controls Growth Factor Stimulation of Raf Activity. Molecular and Cellular Biology. 14(4). 2343–2351. 13 indexed citations
20.
Johnson, Gary L., et al.. (1979). Isolation and characterization of S49 lymphoma cells deficient in beta-adrenergic receptors: relation of receptor number to activation of adenylate cyclase.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15(1). 16–27. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Garth L. Nicolson Breakdown of academic impact, for papers by Julian Downward Breakdown of academic impact, for papers by Jiahuai Han Breakdown of academic impact, for papers by William S. Lane Breakdown of academic impact, for papers by Jacques Pouysségur Breakdown of academic impact, for papers by Guy S. Salvesen Breakdown of academic impact, for papers by Tatsuhiko Kodama Breakdown of academic impact, for papers by Steven A. Carr Breakdown of academic impact, for papers by Elisabetta Dejana Breakdown of academic impact, for papers by Naoyuki Taniguchi
Rankless by CCL
2026